Sp441

EXPLORING THE ROLE OF THE MICROBIOME IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND METABOLIC SYNDROME: PERSPECTIVES FROM RENOWNED EXPERTS

Date
May 19, 2024

Presenters

Speaker Image for Vanessa Leone
University of Wisconsin-Madison
Speaker Image for Guangfu Li
Speaker Image for Ipsita Mohanty
Speaker Image for Rohit Loomba
University of California San Diego

Tracks

Related Products

Thumbnail for MASLD: Novel Insights Into Mechanisms and Future Therapeutic Targets
Thumbnail for A BLOOD-BASED BIOMARKER PANEL FOR NON-INVASIVE DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
A BLOOD-BASED BIOMARKER PANEL FOR NON-INVASIVE DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form metabolic dysfunction-associated steatohepatitis (MASH) are highly prevalent worldwide. However, current non-invasive diagnostic approaches for MASLD and MASH are suboptimal…
Thumbnail for THE GUT MICROBIOTA RHYTHMS IN METABOLIC HOMEOSTASIS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): INSIGHTS FROM MACHINE LEARNING ANALYSES
Thumbnail for PANEL DISCUSSION